Table 3.

Analyzing various laboratory and clinical parameters with the in-hospital mortality.

Impact of ICU stay on mortality
Required ICU stay	Survived	Died	Marginal Row Totals	P value
Yes	7 (7.32) [0.01]	2 (1.68) [0.06]	9	0.764
No	41 (40.68) [0]	9 (9.32) [0.01]	50
Marginal Column Totals	48	11	59 (Grand Total)
Impact of hospital stay on mortality
Hospital stay	Alive	Died	Marginal Row Totals	P value
<5 days	20 (18.71) [0.09]	3 (4.29) [0.39]	23	0.370
>5 days	28 (29.29) [0.06]	8 (6.71) [0.25]	36
Marginal Column Totals	48	11	59 (Grand Total)
Impact of qSOFA stratification on mortality
qSOFA risk category	Survived	Died	Marginal Row Totals	P value
Low risk (0–1 score)	37 (33.36) [0.4]	4 (7.64) [1.74]	41	0.008 OR-0.636 (CI:0.041–0.689) Significant
High risk (2–3 score)	11 (14.64) [0.91]	7 (3.36) [3.96]	18
Marginal Column Totals	48	11	59 (Grand Total)
Impact of cancer type on mortality
Cancer type	Survived	Died	Marginal Row Totals	P value
Colon cancer	6 (5.69) [0.02]	1 (1.31) [0.07]	7
Cancers other than colon cancer	42 (42.31) [0]	10 (9.69) [0.01]	52	0.107
Marginal Column Totals	48	11	59 (Grand Total)
Impact of severity of C. difficile on mortality
C. difficile severity	Survived	Died	Marginal Row Totals	P value
Non severe	26 (23.59) [0.25]	3 (5.41) [1.07]	29	0.752
Severe/Very Severe	22 (24.41) [0.24]	8 (5.59) [1.04]	30
Marginal Column Totals	48	11	59 (Grand Total)
Impact of severity of chemotherapy on mortality
Chemotherapy	Survived	Died	Marginal Row Totals	P value
Yes	29 (26.85) [0.17]	4 (6.15) [0.75]	33	0.147
No	19 (21.15) [0.22]	7 (4.85) [0.96]	26
Marginal Column Totals	48	11	59 (Grand Total)
Impact of rehab/nursing facility stay on mortality
Rehab/Nursing facility	Survived	Died	Marginal Row Totals	P value
Yes	22 (23.59) [0.11]	7 (5.41) [0.47]	29	0.286
No	26 (24.41) [0.1]	4 (5.59) [0.45]	30
Marginal Column Totals	48	11	59 (Grand Total)
Impact of recent hospitalization stay on mortality
Recent hospitalization	Survived	died	Marginal Row Totals	P value
Yes	29 (31.73) [0.23]	10 (7.27) [1.02]	39	0.053
No	19 (16.27) [0.46]	1 (3.73) [2]	20
Marginal Column Totals	48	11	59 (Grand Total)
Impact of recent antibiotics use on mortality
Recent antibiotic use	Survived	Died	Marginal Row Totals	P value
Yes	21 (23.59) [0.29]	8 (5.41) [1.24]	29	0.082
No	27 (24.41) [0.28]	3 (5.59) [1.2]	30
Marginal Column Totals	48	11	59 (Grand Total)
Impact of recent proton pump inhibitors use on mortality
Proton pump inhibitors	Survived	Died	Marginal Row Totals	P value
Yes	23 (23.59) [0.01]	6 (5.41) [0.07]	29	0.691
No	25 (24.41) [0.01]	5 (5.59) [0.06]	30
Marginal column totals	48	11	59 (Grand Total)
Impact of leukocytosis (WBC >15 x109/L) on mortality
WBC >15 x109/L	Survived	Died	Marginal Row Totals	P value
WBC <15	28 (24.41) [0.53]	2 (5.59) [2.31]	30	0.016 OR-0.1587 (CI: 0.030–0.815) Significant
WBC >15	20 (23.59) [0.55]	9 (5.41) [2.39]	29
Marginal Column Totals	48	11	59 (Grand Total)
Impact of anemia (< 90 g/L) on mortality
Hemoglobin (< 90 g/L)	Survived	Died	Marginal Row Totals	P value
Yes	19 (18.71) [0]	4 (4.29) [0.02]	23	0.843
No	29 (29.29) [0]	7 (6.71) [0.01]	36
Marginal Column Totals	48	11	59 (Grand Total)
Impact of renal dysfunction (S. creatinine >1.5 mg/dL) on mortality
S. creatinine	Survived	Dead	Marginal Row Totals	P value
<1.5	33 (33.36) [0]	8 (7.64) [0.02]	41	0.796
>1.5	15 (14.64) [0.01]	3 (3.36) [0.04]	18
Marginal Column Totals	48	11	59 (Grand Total)
Impact of hypoalbuminemia on mortality
S. albumin level (g/dL)	Survived	Died	Marginal Row Totals	P value
<3 g/dL	27 (28.69) [0.1]	10 (8.31) [0.35]	37	0.177
>3 g/dL	11 (9.31) [0.31]	1 (2.69) [1.07]	12
Marginal Column Totals	38	11	49 (Grand Total)
Impact of lactic acidosis on mortality
S. Lactate (mmol/L)	Survived	Died	Marginal Row Totals	P value
<2	16 (15.75) [0]	5 (5.25) [0.01]	21	0.829
>2	8 (8.25) [0.01]	3 (2.75) [0.02]	11
Marginal Column Totals	24	8	32 (Grand Total)